MENU
MCRB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Seres Therapeutics (MCRB) Ownership - Who owns Seres Therapeutics?

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
101 Cambridgepark Drive
Phone
+1 617 945-9626
Employees
233
Web
https://www.serestherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
79.47M
P/E Ratio
N/A
Total Cash
58.85M
Projected Growth
N/A
Total Debt
89.55M
Revenue
N/A
Risk (Beta)
0.06
Dividend Yield
N/A
Total Cash/Share
6.74
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

MCRB
Capitalization
79.5M
P/E Ratio
N/A
Risk (Beta)
0.06
Dividend Yield
N/A
Total Cash
58.8M
Total Cash/Share
6.74
Total Debt
89.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
50.5M
P/B Ratio
1.57
Cash Flow
N/A
Earnings
9.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
2.11
Current Revenue Per Employee
274.68
Dividends Per Share - Security
N/A
EBITDA
-55.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
28.87
Shares Held By Institutions
65.1M
Shares Outstanding - Current
8.73M
Total Liabilities
114M
Total Volume MTD
N/A
Value
1
Gain YTD
-45.247
View a ticker or compare two or three
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel treatments for diseases related to the human microbiome

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
101 Cambridgepark Drive
Phone
+1 617 945-9626
Employees
233
Web
https://www.serestherapeutics.com